Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$45.35 - $57.91 $335,590 - $428,534
-7,400 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$52.6 - $63.29 $1.34 Million - $1.61 Million
-25,500 Reduced 77.51%
7,400 $389,000
Q1 2019

May 07, 2019

BUY
$39.99 - $53.48 $1.32 Million - $1.76 Million
32,900 New
32,900 $1.74 Million
Q2 2018

Aug 08, 2018

SELL
$38.7 - $50.15 $3.72 Million - $4.82 Million
-96,200 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$39.6 - $65.9 $3.81 Million - $6.34 Million
96,200 New
96,200 $4.65 Million
Q4 2017

Feb 12, 2018

SELL
$29.7 - $45.7 $683,100 - $1.05 Million
-23,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$25.1 - $31.05 $577,300 - $714,150
23,000
23,000 $714,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.